Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vancomycin Dosing for Serious MRSA Infections: A Non-inferiority Randomized Trial of Trough Level Versus AUC/MIC

NCT04793152 is registered in ClinicalTrials.gov with Anthony Bai as lead sponsor.

NCT NCT04793152
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04793152 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vancomycin Dosing for Serious MRSA Infections: A Non-inferiority Randomized Trial of Trough Level Versus AUC/MIC
Lead sponsor
Anthony Bai
Phase
Not applicable
Overall status
Recruiting
Start date
March 20, 2023
Completion date
October 31, 2029
Enrollment
700 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

mrsa